Epidemiological and etiological considerations in osteonecrosis.
Authors
Boettcher WG
Source
Dysbarism-related osteonecrosis: proceedings of a symposium on dysbaric osteonecrosis. Beckman EL, Elliott DH, eds. Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 75-153, 1974 Jan; :87-90
Clinical and epidemiological characteristics of aseptic bone necrosis were examined as they affect the general population, excluding individuals who were subjected to decompression. Fifty patients afflicted with femoral head necrosis were studied. Age played no part in the occurrence of this condition. Most patients had symptoms for an average of 18 months prior to diagnosis; some had symptoms for 5 years. In these 50 patients, a total of 86 hips were diseased. In addition to osteonecrosis, these patients shared the following factors: excessive alcohol consumption, 37; hepatic disease, 21; gout or hyperuricemia, 16; thrombocytopenia, 15; thrombocythemia, six; steroid therapy, nine; hypercholesteremia, five; and one each for hyperlipidemia, discoid lupus erythematosus, systemic lupus erythematosus, Fabry's disease, Raynaud's disease, and Gaucher's disease. Bleeding and coagulation disorders were unusually frequent. Platelet counts were made of 37 of the patients; 15 had low values and the platelets of six were elevated. The low values ranged down to 4000; elevated ones, as high as 1.5 million. Further testing revealed evidence of a bleeding or clotting disorder in 26 of the 50 patients. The presence of increased concentrations of serum uric-acid was also statistically significant in the patient population. The authors conclude that femoral head necrosis is a skeletal expression of a systemic disease, or diseases, which by a variety of different events may result in sludging, thrombosis, or hemorrhage in an area of very susceptible blood supply.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.